Jeff Yass’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$585K Sell
12,600
-81,300
-87% -$2.93M ﹤0.01% 9546
2026
Q1
$2.3M Buy
93,900
+82,500
+724% +$1.95M ﹤0.01% 5836
2025
Q4
$283K Sell
11,400
-62,500
-85% -$1.66M ﹤0.01% 10083
2025
Q3
$2.1M Buy
+73,900
New +$2M ﹤0.01% 5688
2024
Q4
Sell
-8,500
Closed -$492K 13402
2024
Q3
$492K Sell
8,500
-2,000
-19% -$98.3K ﹤0.01% 8499
2024
Q2
$426K Sell
10,500
-51,400
-83% -$2.04M ﹤0.01% 8671
2024
Q1
$2.6M Buy
61,900
+35,800
+137% +$1.4M ﹤0.01% 4792
2023
Q4
$1,000K Buy
+26,100
New +$869K ﹤0.01% 6996
2023
Q3
Sell
-47,500
Closed -$1.5M 13155
2023
Q2
$1.5M Buy
47,500
+15,600
+49% +$535K ﹤0.01% 5775
2023
Q1
$1.16M Buy
31,900
+20,800
+187% +$728K ﹤0.01% 6421
2022
Q4
$328K Sell
11,100
-42,300
-79% -$1.36M ﹤0.01% 8879
2022
Q3
$2.08M Buy
53,400
+15,700
+42% +$719K ﹤0.01% 4842
2022
Q2
$1.46M Sell
37,700
-14,200
-27% -$540K ﹤0.01% 5612
2022
Q1
$2.52M Sell
51,900
-10,800
-17% -$557K ﹤0.01% 4970
2021
Q4
$4.61M Sell
62,700
-4,900
-7% -$403K ﹤0.01% 3888
2021
Q3
$6.16M Buy
+67,600
New +$5.75M ﹤0.01% 3597

Other funds holding ASTH

Jeff Yass's ASTH Position: Q2 2026 in Review

Jeff Yass increased its Astrana Health (ASTH) stake by 118% in Q2 2026, buying an estimated $1.49M and bringing the position to 76,338 shares worth $3.54M. The position accounts for ﹤0.01% of the portfolio, ranked #5290.

Jeff Yass first reported a position in ASTH in Q1 2018 and has held it in 23 quarters since. 207 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Jeff Yass held 76,338 shares of Astrana Health worth $3.54M as of Q2 2026.
  • Jeff Yass bought 41,271 Astrana Health shares in Q2 2026, an estimated $1.49M.
  • Astrana Health made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #5290 holding.
  • Jeff Yass first reported a position in Astrana Health in Q1 2018 and has held it in 23 quarters since.
  • 207 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.